Max Walker

1.7k total citations
12 papers, 597 citations indexed

About

Max Walker is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Max Walker has authored 12 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 7 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Max Walker's work include Cholesterol and Lipid Metabolism (5 papers), Peroxisome Proliferator-Activated Receptors (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). Max Walker is often cited by papers focused on Cholesterol and Lipid Metabolism (5 papers), Peroxisome Proliferator-Activated Receptors (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). Max Walker collaborates with scholars based in United States, United Kingdom and France. Max Walker's co-authors include Colin H. Macphee, Mark Burgert, Bryan E. Hoffman, Ping Zhang, Emile R. Mohler, Jisheng Yang, James G. Bollinger, Rosanna C. Mirabile, Damir Hamamdzic and Christine L. Webb and has published in prestigious journals such as Nature Medicine, Biochemical and Biophysical Research Communications and Journal of Lipid Research.

In The Last Decade

Max Walker

11 papers receiving 583 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Max Walker United States 10 292 226 143 82 77 12 597
Hailing Liao United States 14 283 1.0× 417 1.8× 120 0.8× 108 1.3× 72 0.9× 18 811
Angie T. Oler United States 10 381 1.3× 341 1.5× 88 0.6× 77 0.9× 97 1.3× 13 750
Hanny Wassef Canada 13 624 2.1× 250 1.1× 152 1.1× 106 1.3× 128 1.7× 17 876
Akashi Izumi Japan 11 211 0.7× 226 1.0× 111 0.8× 60 0.7× 31 0.4× 12 550
Stefan Jäckle Germany 18 237 0.8× 471 2.1× 122 0.9× 61 0.7× 137 1.8× 26 752
Pilar Mozas Spain 12 371 1.3× 133 0.6× 117 0.8× 42 0.5× 178 2.3× 21 551
Hansook Kim Chong United States 9 213 0.7× 326 1.4× 139 1.0× 135 1.6× 58 0.8× 11 671
Francine Sirois Canada 14 345 1.2× 266 1.2× 102 0.7× 34 0.4× 107 1.4× 22 694
Susan M. Meyn United States 13 335 1.1× 269 1.2× 97 0.7× 54 0.7× 214 2.8× 21 676
Jheem D. Medh United States 16 198 0.7× 322 1.4× 123 0.9× 176 2.1× 147 1.9× 29 846

Countries citing papers authored by Max Walker

Since Specialization
Citations

This map shows the geographic impact of Max Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Walker more than expected).

Fields of papers citing papers by Max Walker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Walker. The network helps show where Max Walker may publish in the future.

Co-authorship network of co-authors of Max Walker

This figure shows the co-authorship network connecting the top 25 collaborators of Max Walker. A scholar is included among the top collaborators of Max Walker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max Walker. Max Walker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
Felt, Adrienne Porter, Robert W. Reeder, Helen Harris, et al.. (2016). Rethinking Connection Security Indicators. Symposium On Usable Privacy and Security. 1–14. 46 indexed citations
3.
Toh, Sue‐Anne, John S. Millar, Jeffrey T. Billheimer, et al.. (2011). PPARγ activation redirects macrophage cholesterol from fecal excretion to adipose tissue uptake in mice via SR-BI. Biochemical Pharmacology. 81(7). 934–941. 17 indexed citations
4.
Briand, François, Snehal Naik, Ilia V. Fuki, et al.. (2009). Both the Peroxisome Proliferator‐Activated Receptor δ Agonist, GW0742, and Ezetimibe Promote Reverse Cholesterol Transport in Mice by Reducing Intestinal Reabsorption of HDL‐Derived Cholesterol. Clinical and Translational Science. 2(2). 127–133. 63 indexed citations
5.
Sprecher, Dennis L., et al.. (2009). Mechanism of inhibition defines CETP activity: a mathematical model for CETP in vitro. Journal of Lipid Research. 50(11). 2222–2234. 16 indexed citations
6.
Fouchet, Marie-Hélène, Anne Bouillot, Christophe Junot, et al.. (2008). Design and evaluation of a novel series of 2,3-oxidosqualene cyclase inhibitors with low systemic exposure, relationship between pharmacokinetic properties and ocular toxicity. Bioorganic & Medicinal Chemistry. 16(11). 6218–6232. 14 indexed citations
7.
Fisher, P. J., et al.. (2008). The number of single nucleotide polymorphisms and on-farm data required for whole-herd parentage testing in dairy cattle herds. Journal of Dairy Science. 92(1). 369–374. 32 indexed citations
8.
Knouff, Christopher W., Noha Lim, Kijoung Song, et al.. (2008). Pharmacological effects of lipid-lowering drugs recapitulate with a larger amplitude the phenotypic effects of common variants within their target genes. Pharmacogenetics and Genomics. 18(12). 1051–1057. 6 indexed citations
9.
Steger, David J., Shree Joshi, Jon L. Collins, et al.. (2008). Selective Partial Agonism of Liver X Receptor α Is Related to Differential Corepressor Recruitment. Molecular Endocrinology. 22(10). 2241–2249. 26 indexed citations
10.
Wilensky, Robert L., Yi Shi, Emile R. Mohler, et al.. (2008). Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development. Nature Medicine. 14(10). 1059–1066. 294 indexed citations
11.
Grand‐Perret, Thierry, et al.. (2001). SCAP ligands are potent new lipid-lowering drugs. Nature Medicine. 7(12). 1332–1338. 47 indexed citations
12.
Talmud, Philippa J., Jutta Palmen, & Max Walker. (1998). Identification of Genetic Variation in the Human Hormone-Sensitive Lipase Gene and 5′ Sequences: Homology of 5′ Sequences with Mouse Promoter and Identification of Potential Regulatory Elements. Biochemical and Biophysical Research Communications. 252(3). 661–668. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hailing Liao Breakdown of academic impact, for papers by Angie T. Oler Breakdown of academic impact, for papers by Hanny Wassef Breakdown of academic impact, for papers by Akashi Izumi Breakdown of academic impact, for papers by Stefan Jäckle Breakdown of academic impact, for papers by Pilar Mozas Breakdown of academic impact, for papers by Hansook Kim Chong Breakdown of academic impact, for papers by Francine Sirois Breakdown of academic impact, for papers by Susan M. Meyn Breakdown of academic impact, for papers by Jheem D. Medh
Rankless by CCL
2026